Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Jan 2012. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 149601000001119 | Alli 27mg chewable tablets (GlaxoSmithKline Consumer Healthcare UK Ltd) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 149621000001114 | Alli 27mg chewable tablets (GlaxoSmithKline Consumer Healthcare UK Ltd) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2886471000001117 | Alli 27mg chewable tablets (Haleon UK Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2886481000001115 | Alli 27mg chewable tablets (Haleon UK Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 66885001000001119 | Alli 27mg chewable tablets (GlaxoSmithKline Consumer Healthcare) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 66885101000001118 | Alli 27mg chewable tablets (GlaxoSmithKline Consumer Healthcare) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Alli 27mg chewable tablets (Haleon UK Ltd) 84 tablet | Has AMP | True | Alli 27mg chewable tablets (Haleon UK Ltd) | Inferred relationship | Existential restriction modifier | |
| Alli 27mg chewable tablets (Haleon UK Ltd) 120 tablet | Has AMP | True | Alli 27mg chewable tablets (Haleon UK Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets